Alternative Therapeutic Interventions: Antimicrobial Peptides and Small Molecules to Treat Microbial Keratitis

Area of Science:

• Ophthalmology
• Microbiology
• Pharmacology

Background:

• Microbial keratitis is a major cause of blindness, affecting millions annually.
• Bacterial and fungal infections are primary causes of corneal ulcers.
• Increasing antimicrobial resistance to conventional treatments poses a significant clinical challenge.

Purpose of the Study:

• To review alternative therapeutic interventions for microbial keratitis.
• To explore the potential of antimicrobial peptides (AMPs), small molecules, and natural compounds.
• To discuss drug delivery systems for optimal treatment of corneal infections.

Main Methods:

• Literature review of current research on alternative therapies for microbial keratitis.
• Analysis of the efficacy and mechanisms of AMPs, small molecules, and natural compounds.
• Examination of various drug delivery systems for corneal infections.

Main Results:

• Antimicrobial peptides (AMPs), small molecules targeting virulence factors, and natural compounds show promise.
• These alternatives offer potential solutions to combat rising antimicrobial resistance.
• Diverse drug delivery systems can enhance the efficacy of these novel treatments.

Conclusions:

• Antimicrobial peptides, small molecules, and natural compounds represent viable alternatives to combat antimicrobial resistance in microbial keratitis.
• Optimized drug delivery systems are crucial for effective treatment of corneal infections.
• Further research is warranted to translate these findings into clinical practice.